Adwe Prenatal Vitamin Recalled for Folic Acid Potency Concerns
DNE Nutraceuticals Inc. is recalling Adwe Prenatal tablets due to a concern regarding the potency of folic acid. The recall affects 1,200 bottles distributed in New York.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a potency concern (under-dosing) rather than a high-risk pathogen or acute injury, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
DNE Nutraceuticals Inc. is recalling Adwe Prenatal tablets, manufactured for Adwe Laboratories, due to a concern regarding the potency of folic acid. The product is identified by Lot 8990 and UPC 040168805079.
The recall involves 1,200 bottles of the product. Distribution was limited to New York. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions or a refund.
The recalled product
- Product
- Adwe Naturals Prenatal Vitamin Manufactured for: Adwe Laboratories 1274 49 Street Brooklyn, NY 11219 UPC 040168805079
- Manufacturer
- DNE Nutraceuticals Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 1,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 8990
Distribution
Distributed in 1 state:
Related recalls
Same hazard · potency concern
See all →- HighEquate Tartar Control Plus Mouthwash Recalled for Out-of-Specification Formula
FDA (Drugs) · 2022-06-08
Other drug recalls
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02